Anti-Human SOST Recombinant Antibody(Blosozumab)

Product Information

Catalog Number	YR1254
Product Name	Anti-Human SOST Recombinant Antibody(Blosozumab)
Molecular Name	Blosozumab
Alias	Anti-SOST Recombinant Antibody, Research Grade Blosozumab
CAS Number	1132758-87-2
Target	SOST[Homo sapiens]
Isotype	IgG4 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	FuncS, IF, Neut, ELISA, FCM, IP
Buffer	PBS, pH7.5
Background	Blosozumab binds SOST, a negative regulator of osteoblast activity. Blocking SOST activity can lead to increased bone density. Blosozaumab has been studied with regards to the treatment of osteoporosis in both men and postmenopausal women. Clinical trials with Blosozumab have shown the antibody to be well tolerated and effective in producing a bone anabolic effect.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price